Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law BPC 157: Miracle Healing Peptide or Hidden Danger? The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA moves toward easing restrictions on certain peptides BioPharma Dive FDA releases denial letters for unapproved drugs, a step toward transparency